Vir Biotechnology Inc (NASDAQ: VIR) kicked off on Tuesday, up 6.33% from the previous trading day, before settling in for the closing price of $5.37. Over the past 52 weeks, VIR has traded in a range of $4.16-$14.45.
Healthcare Sector giant saw their annual sales slid by -18.74% over the last five years. While this was happening, its average annual earnings per share was recorded 9.04%. With a float of $92.68 million, this company’s outstanding shares have now reached $139.02 million.
Vir Biotechnology Inc (VIR) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Vir Biotechnology Inc is 33.38%, while institutional ownership is 56.68%. The most recent insider transaction that took place on Nov 05 ’25, was worth 12,307. In this transaction EVP, General Counsel, Corp Sec of this company sold 2,385 shares at a rate of $5.16, taking the stock ownership to the 78,210 shares. Before that another transaction happened on Nov 05 ’25, when Company’s Officer proposed sale 2,385 for $5.16, making the entire transaction worth $12,307.
Vir Biotechnology Inc (VIR) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.76 earnings per share (EPS), higher than consensus estimate (set at -0.87) by 0.11. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.69 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 9.04% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 14.14% during the next five years compared to -18.74% drop over the previous five years of trading.
Vir Biotechnology Inc (NASDAQ: VIR) Trading Performance Indicators
Take a look at Vir Biotechnology Inc’s (VIR) current performance indicators. Last quarter, stock had a quick ratio of 7.25. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 47.12.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.62, a number that is poised to hit -0.65 in the next quarter and is forecasted to reach -2.93 in one year’s time.
Technical Analysis of Vir Biotechnology Inc (VIR)
Analysing the last 5-days average volume posted by the [Vir Biotechnology Inc, VIR], we can find that recorded value of 1.44 million was lower than the volume posted last year of 1.54 million. As of the previous 9 days, the stock’s Stochastic %D was 39.86%.
During the past 100 days, Vir Biotechnology Inc’s (VIR) raw stochastic average was set at 64.79%, which indicates a significant increase from 51.44% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.37 in the past 14 days, which was higher than the 0.30 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.56, while its 200-day Moving Average is $6.04. Now, the first resistance to watch is $5.85. This is followed by the second major resistance level at $6.00. The third major resistance level sits at $6.26. If the price goes on to break the first support level at $5.45, it is likely to go to the next support level at $5.19. Now, if the price goes above the second support level, the third support stands at $5.04.
Vir Biotechnology Inc (NASDAQ: VIR) Key Stats
The company with the Market Capitalisation of 794.40 million has total of 139,125K Shares Outstanding. Its annual sales at the moment are 74,210 K in contrast with the sum of -521,960 K annual income. Company’s last quarter sales were recorded 240 K and last quarter income was -163,140 K.
